Publication | Closed Access

Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents

Medicinal ChemistryDerivative (Chemistry)DerivativesAntiparasitic AgentMedicineAnti-cancer AgentPotential Antitumor AgentsHeterocycle ChemistryPharmacological EvaluationPharmacology-One DerivativesPharmaceutical ChemistryBiomolecular EngineeringDrug Discovery